Structure Therapeutics (GPCR) Total Liabilities (2022 - 2026)

Structure Therapeutics' Total Liabilities history runs 5 years deep, the most recent figure standing at $61.0 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 45.62% year-over-year to $61.0 million; the TTM figure through Mar 2026 stood at $61.0 million (up 45.62% YoY), while the FY2025 annual figure was $67.5 million, up 75.49% from the prior year.
• Total Liabilities was $61.0 million for Q1 2026 at Structure Therapeutics, down from $67.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $103.9 million in Q3 2022 to a low of $11.0 million in Q1 2023.
• Historically, Total Liabilities has averaged $45.3 million across 5 years, with a median of $38.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities slumped 85.75% in 2023, then soared 149.11% in 2024.
• A 5-year view of Total Liabilities shows it stood at $13.0 million in 2022, then soared by 123.3% to $29.1 million in 2023, then jumped by 32.48% to $38.5 million in 2024, then surged by 75.49% to $67.5 million in 2025, then fell by 9.64% to $61.0 million in 2026.
• The last three Total Liabilities figures came in at $61.0 million (Q1 2026), $67.5 million (Q4 2025), and $62.1 million (Q3 2025), per Business Quant data.